Literature DB >> 30374766

Response to Crevenna and Ashbury, Vallance and Bolam, and Crevenna and Keilani regarding the effects of exercise on chemotherapy-induced peripheral neuropathy.

Ian R Kleckner1,2, Charles Kamen3, Jennifer S Gewandter3, Nimish A Mohile3, Charles E Heckler3, Eva Culakova3, Chunkit Fung3, Michelle C Janelsins3, Matthew Asare3, Po-Ju Lin3, Pavan S Reddy4, Jeffrey Giguere5, Jeffrey Berenberg6, Shelli R Kesler7, Karen M Mustian3.   

Abstract

Entities:  

Mesh:

Year:  2018        PMID: 30374766      PMCID: PMC6381835          DOI: 10.1007/s00520-018-4528-z

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


× No keyword cloud information.
  10 in total

1.  Measures of clinical significance.

Authors:  Helena Chmura Kraemer; George A Morgan; Nancy L Leech; Jeffrey A Gliner; Jerry J Vaske; Robert J Harmon
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2003-12       Impact factor: 8.829

Review 2.  National Cancer Institute-supported chemotherapy-induced peripheral neuropathy trials: outcomes and lessons.

Authors:  Neil Majithia; Sarah M Temkin; Kathryn J Ruddy; Andreas S Beutler; Dawn L Hershman; Charles L Loprinzi
Journal:  Support Care Cancer       Date:  2015-12-19       Impact factor: 3.603

3.  Letter to the editor-comments on Kleckner et al. (2018) "Effects of exercise during chemotherapy-induced peripheral neuropathy: a multicenter, randomized controlled trial".

Authors:  J K Vallance; K A Bolam
Journal:  Support Care Cancer       Date:  2018-07-22       Impact factor: 3.603

4.  Chemotherapy-induced peripheral neuropathy-more high-quality research is needed.

Authors:  Richard Crevenna; Mohammad Keilani
Journal:  Support Care Cancer       Date:  2018-07-25       Impact factor: 3.603

Review 5.  Research designs for proof-of-concept chronic pain clinical trials: IMMPACT recommendations.

Authors:  Jennifer S Gewandter; Robert H Dworkin; Dennis C Turk; Michael P McDermott; Ralf Baron; Marc R Gastonguay; Ian Gilron; Nathaniel P Katz; Cyrus Mehta; Srinivasa N Raja; Stephen Senn; Charles Taylor; Penney Cowan; Paul Desjardins; Rozalina Dimitrova; Raymond Dionne; John T Farrar; David J Hewitt; Smriti Iyengar; Gary W Jay; Eija Kalso; Robert D Kerns; Richard Leff; Michael Leong; Karin L Petersen; Bernard M Ravina; Christine Rauschkolb; Andrew S C Rice; Michael C Rowbotham; Cristina Sampaio; Sren H Sindrup; Joseph W Stauffer; Ilona Steigerwald; Jonathan Stewart; Jeffrey Tobias; Rolf-Detlef Treede; Mark Wallace; Richard E White
Journal:  Pain       Date:  2014-05-24       Impact factor: 6.961

6.  Physical interventions for patients suffering from chemotherapy-induced polyneuropathy.

Authors:  Richard Crevenna; Fredrick D Ashbury
Journal:  Support Care Cancer       Date:  2018-01-27       Impact factor: 3.603

Review 7.  Chemotherapy-induced peripheral neuropathy clinical trials: Review and recommendations.

Authors:  Jennifer S Gewandter; Roy Freeman; Rachel A Kitt; Guido Cavaletti; Lynn R Gauthier; Michael P McDermott; Nimish A Mohile; Supriya G Mohlie; A Gordon Smith; Mohamedtaki A Tejani; Dennis C Turk; Robert H Dworkin
Journal:  Neurology       Date:  2017-07-26       Impact factor: 9.910

8.  Natural history of paclitaxel-associated acute pain syndrome: prospective cohort study NCCTG N08C1.

Authors:  Charles L Loprinzi; Brandi N Reeves; Shaker R Dakhil; Jeff A Sloan; Sherry L Wolf; Kelli N Burger; Arif Kamal; Nguyet A Le-Lindqwister; Gamini S Soori; Anthony J Jaslowski; Paul J Novotny; Daniel H Lachance
Journal:  J Clin Oncol       Date:  2011-03-07       Impact factor: 44.544

9.  Effects of exercise during chemotherapy on chemotherapy-induced peripheral neuropathy: a multicenter, randomized controlled trial.

Authors:  Ian R Kleckner; Charles Kamen; Jennifer S Gewandter; Nimish A Mohile; Charles E Heckler; Eva Culakova; Chunkit Fung; Michelle C Janelsins; Matthew Asare; Po-Ju Lin; Pavan S Reddy; Jeffrey Giguere; Jeffrey Berenberg; Shelli R Kesler; Karen M Mustian
Journal:  Support Care Cancer       Date:  2017-12-14       Impact factor: 3.603

10.  Exercise for Toxicity Management in Cancer-A Narrative Review.

Authors:  Ian R Kleckner; Richard F Dunne; Matthew Asare; Calvin Cole; Fergal Fleming; Chunkit Fung; Po-Ju Lin; Karen M Mustian
Journal:  Oncol Hematol Rev       Date:  2018-02-15
  10 in total
  2 in total

1.  Effects of exercise on inflammation in patients receiving chemotherapy: a nationwide NCORP randomized clinical trial.

Authors:  Ian R Kleckner; Charles Kamen; Calvin Cole; Chunkit Fung; Charles E Heckler; Joseph J Guido; Eva Culakova; Adedayo A Onitilo; Alison Conlin; J Philip Kuebler; Supriya Mohile; Michelle Janelsins; Karen M Mustian
Journal:  Support Care Cancer       Date:  2019-04-02       Impact factor: 3.603

2.  Longitudinal study of inflammatory, behavioral, clinical, and psychosocial risk factors for chemotherapy-induced peripheral neuropathy.

Authors:  Ian R Kleckner; Todd A Jusko; Eva Culakova; Kaitlin Chung; Amber S Kleckner; Matthew Asare; Julia E Inglis; Kah Poh Loh; Luke J Peppone; Jessica Miller; Marianne Melnik; Samer Kasbari; Deborah Ossip; Karen M Mustian
Journal:  Breast Cancer Res Treat       Date:  2021-06-30       Impact factor: 4.624

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.